Robertet S.A. (RBT.PA)
Grasse, FR
Robertet SA specializes in the creation and distribution of fragrances, flavorings, and a diverse range of natural products. Its operations are strategically divided into three principal divisions: Raw Materials, Fragrances, and Flavors. The company also manufactures organic essential oils and various active ingredients. With a significant global footprint, it conducts business across North America, Europe, the Asia Pacific region, South America, the Caribbean, Africa, and the Middle East. Established in 1850, Robertet SA maintains its corporate headquarters in Grasse, France.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.35% | +3.63% | +4.16% | +3.25% | -8.62% | -5.81% | -1.55% | -1.08% | -17.13% | +206.30% | +2,114.19% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 5 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+4.5% Q4'25: +15.3% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%+10.8% Q4'25: +158.5% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+10.5% Q4'25: +12.9% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+16.4% ★ Q4'25: -21.2% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+15.9% ★ Q4'25: -39.8% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%+3.7% Q4'25: -6.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.39× Q4'25: -0.85× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 1995 actual |
Dec 1996 actual |
Dec 1997 actual |
Dec 1998 actual |
Dec 1999 actual |
Dec 2000 actual |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 6 EPS Ana. |
Dec 2027 8 Rev. Ana. 7 EPS Ana. |
Dec 2028 6 Rev. Ana. 5 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
113.27M
est.
|
113.42M
est.
|
118.59M
est.
|
135.20M
est.
|
151.45M
est.
|
179.40M
est.
|
206.13M
est.
|
210.52M
est.
|
205.08M
est.
|
208.80M
est.
|
207.00M
est: 208.05M (-0.5%)
|
221.13M
est: 223.26M (-1.0%)
|
242.29M
est: 217.71M (+11.3%)
|
303.17M
est: 298.41M (+1.6%)
|
305.09M
est: 309.58M (-1.4%)
|
362.25M
est: 345.10M (+5.0%)
|
435.32M
est: 409.60M (+6.3%)
|
468.29M
est: 425.90M (+10.0%)
|
504.40M
est: 504.40M (0.0%)
|
524.90M
est: 525.00M (0.0%)
|
554.27M
est: 554.30M (0.0%)
|
538.32M
est: 538.30M (+0.0%)
|
606.09M
est: 606.05M (+0.0%)
|
703.04M
est: 699.05M (+0.6%)
|
721.13M
est: 759.29M (-5.0%)
|
807.61M
est: 807.80M (0.0%)
|
843.93M
est: 848.06M (-0.5%)
|
872.67M
861.36M – 880.17M
+2.9% YoY
|
918.85M
894.15M – 932.65M
+5.3% YoY
|
974.88M
974.88M – 974.89M
+6.1% YoY
|
1.02B
1.00B – 1.04B
+5.0% YoY
|
1.08B
1.05B – 1.09B
+5.0% YoY
|
| EBITDA |
20.79M
est.
|
14.82M
est.
|
15.50M
est.
|
16.87M
est.
|
17.50M
est.
|
24.07M
est.
|
27.43M
est.
|
28.47M
est.
|
28.40M
est.
|
31.09M
est.
|
28.60M
est: 29.84M (-4.2%)
|
30.73M
est: 26.29M (+16.9%)
|
29.51M
est: 39.18M (-24.7%)
|
32.16M
est: 53.70M (-40.1%)
|
34.53M
est: 55.71M (-38.0%)
|
49.36M
est: 62.10M (-20.5%)
|
64.27M
est: 75.10M (-14.4%)
|
74.47M
est: 78.18M (-4.7%)
|
83.55M
est: 92.48M (-9.7%)
|
86.55M
est: 96.25M (-10.1%)
|
94.79M
est: 101.63M (-6.7%)
|
89.50M
est: 98.86M (-9.5%)
|
115.44M
est: 111.11M (+3.9%)
|
125.62M
est: 109.09M (+15.2%)
|
132.89M
est: 165.33M (-19.6%)
|
160.03M
est: 175.90M (-9.0%)
|
168.31M
est: 184.66M (-8.9%)
|
190.02M
187.56M – 191.66M
+2.9% YoY
|
200.08M
194.70M – 203.08M
+5.3% YoY
|
212.28M
212.28M – 212.28M
+6.1% YoY
|
222.99M
218.51M – 225.64M
+5.0% YoY
|
234.19M
229.48M – 236.97M
+5.0% YoY
|
| EBIT |
16.86M
est.
|
13.22M
est.
|
13.82M
est.
|
15.05M
est.
|
14.59M
est.
|
20.14M
est.
|
23.32M
est.
|
23.59M
est.
|
23.96M
est.
|
25.25M
est.
|
22.79M
est: 23.69M (-3.8%)
|
24.58M
est: 24.25M (+1.3%)
|
29.18M
est: 31.77M (-8.2%)
|
24.01M
est: 40.07M (-40.1%)
|
25.68M
est: 45.18M (-43.2%)
|
40.10M
est: 50.36M (-20.4%)
|
50.02M
est: 60.90M (-17.9%)
|
59.58M
est: 63.40M (-6.0%)
|
67.21M
est: 75.00M (-10.4%)
|
70.35M
est: 78.06M (-9.9%)
|
74.60M
est: 82.42M (-9.5%)
|
68.35M
est: 80.04M (-14.6%)
|
94.67M
est: 84.39M (+12.2%)
|
102.44M
est: 84.65M (+21.0%)
|
109.41M
est: 136.62M (-19.9%)
|
132.47M
est: 145.35M (-8.9%)
|
138.06M
est: 152.59M (-9.5%)
|
157.02M
154.98M – 158.37M
+2.9% YoY
|
165.33M
160.88M – 167.81M
+5.3% YoY
|
175.41M
175.41M – 175.41M
+6.1% YoY
|
184.26M
180.56M – 186.45M
+5.0% YoY
|
193.51M
189.62M – 195.82M
+5.0% YoY
|
| Net Income |
6.26M
est.
|
5.61M
est.
|
5.87M
est.
|
6.38M
est.
|
6.85M
est.
|
9.59M
est.
|
11.38M
est.
|
12.56M
est.
|
12.96M
est.
|
14.36M
est.
|
13.14M
est: 13.94M (-5.7%)
|
14.19M
est: 14.06M (+0.9%)
|
18.42M
est: 12.25M (+50.3%)
|
13.22M
est: 12.29M (+7.5%)
|
14.36M
est: 14.29M (+0.5%)
|
24.06M
est: 16.86M (+42.7%)
|
35.98M
est: 27.80M (+29.4%)
|
41.64M
est: 29.23M (+42.5%)
|
48.54M
est: 44.03M (+10.2%)
|
51.75M
est: 46.68M (+10.9%)
|
53.05M
est: 48.71M (+8.9%)
|
50.58M
est: 45.69M (+10.7%)
|
71.71M
est: 67.16M (+6.8%)
|
76.02M
est: 70.89M (+7.2%)
|
74.60M
est: 89.07M (-16.3%)
|
90.07M
est: 92.71M (-2.8%)
|
103.43M
est: 103.43M (+0.0%)
|
99.72M
93.52M – 106.82M
-3.6% YoY
|
110.42M
103.48M – 119.60M
+10.7% YoY
|
121.66M
115.63M – 128.43M
+10.2% YoY
|
134.05M
130.54M – 136.12M
+10.2% YoY
|
148.37M
144.49M – 150.66M
+10.7% YoY
|
| SGA |
6.2K
est.
|
38.35M
est.
|
40.11M
est.
|
43.67M
est.
|
45.79M
est.
|
53.18M
est.
|
58.71M
est.
|
58.42M
est.
|
55.92M
est.
|
55.79M
est.
|
36.01M
est: 55.15M (-34.7%)
|
38.47M
est: 62.45M (-38.4%)
|
43.62M
est: 11.6K (+375,102.1%)
|
51.93M
est: 91.70M (-43.4%)
|
—
est: 16.5K (-100.0%)
|
58.14M
est: 18.4K (+315,391.9%)
|
171.13M
est: 22.3K (+767,776.7%)
|
180.65M
est: 23.2K (+778,534.5%)
|
186.92M
est: 27.4K (+680,977.8%)
|
190.46M
est: 28.6K (+666,656.5%)
|
47.0K
est: 30.2K (+55.8%)
|
34.0K
est: 29.3K (+16.1%)
|
267.0K
est: 33.0K (+709.7%)
|
1.02M
est: 149.40M (-99.3%)
|
-1.21M
est: 31.8K (-3,911.5%)
|
—
est: 33.8K (-100.0%)
|
—
est: 35.5K (-100.0%)
|
36.5K
36.0K – 36.8K
+2.9% YoY
|
38.4K
37.4K – 39.0K
+5.3% YoY
|
40.8K
40.8K – 40.8K
+6.1% YoY
|
42.9K
42.0K – 43.4K
+5.0% YoY
|
45.0K
44.1K – 45.5K
+5.0% YoY
|
| EPS |
2.99
est.
|
2.25
est.
|
2.47
est.
|
2.85
est.
|
3.28
est.
|
4.96
est.
|
6.28
est.
|
6.25
est.
|
6.52
est.
|
7.14
est.
|
5.92
est: 7.27 (-18.6%)
|
6.40
est: 7.36 (-13.1%)
|
8.25
est: 5.83 (+41.6%)
|
5.95
est: 5.85 (+1.7%)
|
6.45
est: 6.80 (-5.1%)
|
10.77
est: 8.71 (+23.7%)
|
15.66
est: 13.31 (+17.7%)
|
18.10
est: 13.97 (+29.6%)
|
21.07
est: 21.08 (0.0%)
|
22.41
est: 22.35 (+0.3%)
|
22.96
est: 23.32 (-1.5%)
|
21.88
est: 21.88 (+0.0%)
|
31.00
est: 32.16 (-3.6%)
|
36.41
est: 33.42 (+8.9%)
|
35.71
est: 41.29 (-13.5%)
|
43.05
est: 42.97 (+0.2%)
|
47.68
est: 47.57 (+0.2%)
|
47.09
43.11 – 49.25
-1.0% YoY
|
51.47
47.71 – 55.14
+9.3% YoY
|
57.10
53.31 – 59.21
+10.9% YoY
|
61.80
60.19 – 62.76
+8.2% YoY
|
68.41
66.62 – 69.46
+10.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-06-11 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-06-10 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-06-09 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-06-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-06-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-06-04 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-06-03 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-06-02 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-06-01 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.14% | 1.04M | 0.33% |
| 2 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.14% | 1.45M | 0.58% |
| 3 | Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L | 0.06% | 1.93M | 0.30% |
| 4 | iShares MSCI Europe Small-Cap ETF IEUS | 0.06% | 96.6K | 0.41% |
| 5 | Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist MMS.PA | 0.04% | 310.2K | 0.40% |
| 6 | Avantis International Small Cap Equity ETF AVDS | 0.04% | 124.7K | 0.30% |
| 7 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.03% | 198.2K | 0.30% |
| 8 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.02% | 3.29M | 0.06% |
| 9 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.02% | 51.1K | 0.83% |
| 10 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.02% | 3.08M | 0.40% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jerome Bruhat | Chief Executive Officer | 1M | male |
| Christophe Maubert | Deputy Chairman of the Board | 35.0K | male |
| Olivier Maubert | Global Head of Health & Beauty and Chief Innovation Officer | 5.0K | male |
| Guillaume Castel | Chief Information Officer | — | male |
| Herve Bellon | Chief Operating Officer | — | male |
| Isabelle Pardies | Chief Financial Officer | — | female |
| Eugenie Cossart | General Counsel & Head of Ethics | — | female |
| Julien Maubert | Global Head of Fragrances Division & Director of CSR | — | male |
| Olga Renda blanche | Director of Human Resources | — | — |
| Clélia Revinci | Chief Communication & Digital Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RBT.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
